Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Mar 2023. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
2877251000001119 | Rizatriptan 10mg orodispersible tablets sugar free (Glenmark Pharmaceuticals Europe Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
2877261000001116 | Rizatriptan 10mg orodispersible tablets sugar free (Glenmark Pharmaceuticals Europe Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Rizatriptan 10mg orodispersible tablets sugar free (Glenmark Pharmaceuticals Europe Ltd) 6 tablet | Has AMP | True | Rizatriptan 10mg orodispersible tablets sugar free (Glenmark Pharmaceuticals Europe Ltd) | Inferred relationship | Existential restriction modifier | |
Rizatriptan 10mg orodispersible tablets sugar free (Glenmark Pharmaceuticals Europe Ltd) 3 tablet | Has AMP | True | Rizatriptan 10mg orodispersible tablets sugar free (Glenmark Pharmaceuticals Europe Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets